[Health reporting of poisoning in Germany-a scientific investigation into the establishment of national poisoning monitoring in Germany : Background, preliminary work, requirements].

Gesundheitsberichterstattung über Vergiftungen in Deutschland – Wissenschaftliche Untersuchung zur Einrichtung eines nationalen Monitorings von Vergiftungen in Deutschland : Hintergründe, Vorarbeiten, Anforderungen.
Key data set Poisoning cases Poisoning events Poisoning monitoring Standardization and harmonization of data

Journal

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
ISSN: 1437-1588
Titre abrégé: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Pays: Germany
ID NLM: 101181368

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 7 2 2019
medline: 13 9 2019
entrez: 7 2 2019
Statut: ppublish

Résumé

As a result of decentralized and non-harmonized documentation of poisoning cases within Germany, in comparison to other countries (e.g. the USA, Switzerland, Sweden, and the Netherlands), there is a substantial lack of harmonized national data, in particular for the early detection and risk assessment at the German Federal Institute for Risk Assessment (BfR).The establishment of a national monitoring system for poisonings in Germany is therefore an important step towards enabling faster and more efficient technical access to consolidated accumulated national poisoning data. Additionally, the monitoring would consolidate the publication of annual reports (modelled on the USA National Poison Data System reports) of the German Poison Information Centres and the BfR. Timely assessment of poisoning cases enables fast recognition and confirmation of acute as well as previously unrecognized poisoning hazards. Also relevant here is the safety of products and the associated protection, especially of children, against poisoning accidents.The continuous monitoring and reporting requirements of such a system necessitate additional and challenging work, suitable human resources and IT infrastructure and an annual budget that must be taken into consideration for overall as well as financial planning.

Identifiants

pubmed: 30725113
doi: 10.1007/s00103-019-02886-1
pii: 10.1007/s00103-019-02886-1
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

341-349

Auteurs

Esther Feistkorn (E)

Fachgruppe Expositionsbewertung von gefährlichen Produkten, Bundesinstitut für Risikobewertung (BfR), Max-Dohrn-Straße 8-10, 10589, Berlin, Deutschland. esther.feistkorn@bfr.bund.de.

Matthias Greiner (M)

Fachgruppe Expositionsbewertung von gefährlichen Produkten, Bundesinstitut für Risikobewertung (BfR), Max-Dohrn-Straße 8-10, 10589, Berlin, Deutschland.

Herbert Desel (H)

Fachgruppe Expositionsbewertung von gefährlichen Produkten, Bundesinstitut für Risikobewertung (BfR), Max-Dohrn-Straße 8-10, 10589, Berlin, Deutschland.

Michael Schaefer (M)

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Universität Leipzig, Leipzig, Deutschland.

Adelgunde Graefe (A)

Institut für Rechtsmedizin, Medizinische Fakultät, Universität Leipzig, Leipzig, Deutschland.

Heike Franke (H)

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Universität Leipzig, Leipzig, Deutschland.

Axel Hahn (A)

Fachgruppe Expositionsbewertung von gefährlichen Produkten, Bundesinstitut für Risikobewertung (BfR), Max-Dohrn-Straße 8-10, 10589, Berlin, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH